Suppr超能文献

心脏疾病状态决定个体微小RNA的功能性mRNA靶向谱。

Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.

作者信息

Matkovich Scot J, Dorn Gerald W, Grossenheider Tiffani C, Hecker Peter A

机构信息

From the Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO.

出版信息

Circ Cardiovasc Genet. 2015 Dec;8(6):774-84. doi: 10.1161/CIRCGENETICS.115.001237. Epub 2015 Nov 9.

Abstract

BACKGROUND

MicroRNAs are key players in cardiac stress responses, but the mRNAs, whose abundance and translational potential are primarily affected by changes in cardiac microRNAs, are not well defined. Stimulus-induced, large-scale alterations in the cardiac transcriptome, together with consideration of the law of mass action, further suggest that the mRNAs most substantively targeted by individual microRNAs will vary between unstressed and stressed conditions. To test the hypothesis that microRNA target profiles differ in health and disease, we traced the fate of empirically determined miR-133a and miR-378 targets in mouse hearts undergoing pressure overload hypertrophy.

METHODS AND RESULTS

Ago2 immunoprecipitation with RNA sequencing (RNA-induced silencing complex sequencing) was used for unbiased definition of microRNA-dependent and microRNA-independent alterations occurring among ≈13 000 mRNAs in response to transverse aortic constriction (TAC). Of 37 direct targets of miR-133a defined in unstressed hearts (fold change ≥25%, false discovery rate <0.02), only 4 (11%) continued to be targeted by miR-133a during TAC, whereas for miR-378 direct targets, 3 of 32 targets (9%) were maintained during TAC. Similarly, only 16% (for miR-133a) and 53% (for miR-378) of hundreds of indirectly affected mRNAs underwent comparable regulation, demonstrating that the effect of TAC on microRNA direct target selection resulted in widespread alterations of signaling function. Numerous microRNA-mediated regulatory events occurring exclusively during pressure overload revealed signaling networks that may be responsive to the endogenous decreases in miR-133a during TAC.

CONCLUSIONS

Pressure overload-mediated changes in overall cardiac RNA content alter microRNA targeting profiles, reinforcing the need to define microRNA targets in tissue-, cell-, and status-specific contexts.

摘要

背景

微小RNA是心脏应激反应的关键参与者,但那些丰度和翻译潜力主要受心脏微小RNA变化影响的信使核糖核酸尚未得到很好的定义。刺激诱导的心脏转录组大规模改变,以及对质量作用定律的考虑,进一步表明,在无应激和应激条件下,单个微小RNA最主要靶向的信使核糖核酸会有所不同。为了验证微小RNA靶标谱在健康和疾病状态下存在差异这一假设,我们追踪了在经历压力超负荷肥大的小鼠心脏中,经实验确定的miR - 133a和miR - 378靶标的命运。

方法与结果

采用AGO2免疫沉淀结合RNA测序(RNA诱导沉默复合体测序),以无偏倚地定义在约13000个信使核糖核酸中,因横断主动脉缩窄(TAC)而发生的微小RNA依赖性和微小RNA非依赖性改变。在无应激心脏中定义的37个miR - 133a直接靶标(倍数变化≥25%,错误发现率<0.02)中,只有4个(11%)在TAC期间继续被miR - 133a靶向,而对于miR - 378直接靶标,32个靶标中的3个(9%)在TAC期间得以维持。同样,数百个间接受影响的信使核糖核酸中,只有16%(对于miR - 133a)和53%(对于miR - 378)经历了类似的调控,这表明TAC对微小RNA直接靶标选择的影响导致了信号功能的广泛改变。许多仅在压力超负荷期间发生的微小RNA介导的调控事件揭示了可能对TAC期间miR - 133a内源性降低有反应的信号网络。

结论

压力超负荷介导的心脏整体RNA含量变化改变了微小RNA的靶向谱,强化了在组织、细胞和状态特异性背景下定义微小RNA靶标的必要性。

相似文献

1
Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.
Circ Cardiovasc Genet. 2015 Dec;8(6):774-84. doi: 10.1161/CIRCGENETICS.115.001237. Epub 2015 Nov 9.
3
HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
Circ Heart Fail. 2015 Nov;8(6):1094-104. doi: 10.1161/CIRCHEARTFAILURE.114.001781. Epub 2015 Sep 14.
4
RISC RNA sequencing for context-specific identification of in vivo microRNA targets.
Circ Res. 2011 Jan 7;108(1):18-26. doi: 10.1161/CIRCRESAHA.110.233528. Epub 2010 Oct 28.
5
Exploring miRNA-mRNA regulatory network in cardiac pathology in Na/H exchanger isoform 1 transgenic mice.
Physiol Genomics. 2018 Oct 1;50(10):846-861. doi: 10.1152/physiolgenomics.00048.2018. Epub 2018 Jul 20.
6
Regulation of cardiac microRNAs by cardiac microRNAs.
Circ Res. 2013 Jun 21;113(1):62-71. doi: 10.1161/CIRCRESAHA.113.300975. Epub 2013 Apr 26.
7
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
J Mol Cell Cardiol. 2015 Apr;81:1-9. doi: 10.1016/j.yjmcc.2015.01.008. Epub 2015 Jan 26.
8
Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.
Circ Res. 2012 Aug 17;111(5):521-31. doi: 10.1161/CIRCRESAHA.112.265736. Epub 2012 Jun 29.
10
MicroRNA-150 Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
J Cell Biochem. 2015 Oct;116(10):2166-76. doi: 10.1002/jcb.25057.

引用本文的文献

1
Metabolomic and transcriptomic signatures of chemogenetic heart failure.
Am J Physiol Heart Circ Physiol. 2022 Mar 1;322(3):H451-H465. doi: 10.1152/ajpheart.00628.2021. Epub 2022 Jan 28.
2
Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA-34a.
Exp Ther Med. 2017 Dec;14(6):5497-5502. doi: 10.3892/etm.2017.5216. Epub 2017 Sep 27.
3
The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.
Mol Ther. 2017 Mar 1;25(3):694-704. doi: 10.1016/j.ymthe.2017.01.012. Epub 2017 Feb 12.

本文引用的文献

1
Acute targeting of general transcription factor IIB restricts cardiac hypertrophy via selective inhibition of gene transcription.
Circ Heart Fail. 2015 Jan;8(1):138-48. doi: 10.1161/CIRCHEARTFAILURE.114.001660. Epub 2014 Nov 14.
2
Structural basis for microRNA targeting.
Science. 2014 Oct 31;346(6209):608-13. doi: 10.1126/science.1258040.
4
Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs.
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12264-9. doi: 10.1073/pnas.1410622111. Epub 2014 Jul 28.
5
Identification and consequences of miRNA-target interactions--beyond repression of gene expression.
Nat Rev Genet. 2014 Sep;15(9):599-612. doi: 10.1038/nrg3765. Epub 2014 Jul 15.
6
MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.
Circ Res. 2014 Jul 7;115(2):273-83. doi: 10.1161/CIRCRESAHA.115.303252. Epub 2014 May 7.
7
Inhibition of miR-25 improves cardiac contractility in the failing heart.
Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12.
8
Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
Circ Res. 2014 May 9;114(10):1585-95. doi: 10.1161/CIRCRESAHA.114.303784. Epub 2014 Mar 21.
10
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
Circulation. 2013 May 28;127(21):2097-106. doi: 10.1161/CIRCULATIONAHA.112.000882. Epub 2013 Apr 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验